Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline

OBJECTIVES: Preclinical Alzheimers disease (AD) patients may or may not show cognitive impairment on testing. AD biomarkers are central to the identification of those at low, intermediate, or high risk of later dementia due to AD. We investigated biomarker distribution in those identified as subject...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Brain Behav
Prif Awduron: Eliassen, Carl F., Reinvang, Ivar, Selnes, Per, Grambaite, Ramune, Fladby, Tormod, Hessen, Erik
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2017
Pynciau:
Original Research
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5607543/
https://ncbi.nlm.nih.gov/pubmed/28948074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.776
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg